192 related articles for article (PubMed ID: 35468369)
21. Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene.
Azevedo C; Chumarina M; Serafimova E; Goldwurm S; Collin A; Roybon L; Savchenko E; Pomeshchik Y
Stem Cell Res; 2020 Mar; 43():101694. PubMed ID: 31954327
[TBL] [Abstract][Full Text] [Related]
22. MFN2 transcripts escaping from nonsense-mediated mRNA decay pathway cause Charcot-Marie-Tooth disease type 2A2.
Kawarai T; Yamasaki K; Mori A; Takamatsu N; Osaki Y; Banzrai C; Miyamoto R; Oki R; Pedace L; Orlacchio A; Nodera H; Hashiguchi A; Higuchi Y; Takashima H; Nishida Y; Izumi Y; Kaji R
J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1263-1265. PubMed ID: 27154191
[No Abstract] [Full Text] [Related]
23. Generation of the human induced pluripotent stem cell line PUMCi005-A from a patient with Perrault syndrome.
Wang YB; Lv YF; Zhang Y; Wang W
Stem Cell Res; 2024 Mar; 75():103318. PubMed ID: 38295749
[TBL] [Abstract][Full Text] [Related]
24. MFN2 mutations in Charcot-Marie-Tooth disease alter mitochondria-associated ER membrane function but do not impair bioenergetics.
Larrea D; Pera M; Gonnelli A; Quintana-Cabrera R; Akman HO; Guardia-Laguarta C; Velasco KR; Area-Gomez E; Dal Bello F; De Stefani D; Horvath R; Shy ME; Schon EA; Giacomello M
Hum Mol Genet; 2019 Jun; 28(11):1782-1800. PubMed ID: 30649465
[TBL] [Abstract][Full Text] [Related]
25. An integration-free iPSC line (SDQLCHi017-A) derived from a patient with nemaline myopathy-2 disease carrying compound heterozygote mutations in NEB gene.
Ma Y; Zhang H; Li X; Yang X; Li Y; Guan J; Lv Y; Gai Z; Liu Y
Stem Cell Res; 2020 Mar; 43():101729. PubMed ID: 32062132
[TBL] [Abstract][Full Text] [Related]
26. Charcot-Marie-Tooth disease type 2A with an autosomal-recessive inheritance: the first report of an adult-onset disease.
Hikiami R; Yamashita H; Koita N; Jingami N; Sawamoto N; Furukawa K; Kawai H; Terashima T; Oka N; Hashiguchi A; Takashima H; Urushitani M; Takahashi R
J Hum Genet; 2018 Jan; 63(1):89-92. PubMed ID: 29215088
[TBL] [Abstract][Full Text] [Related]
27. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
28. Generation of an induced pluripotent stem cell line (SDASi001-A) from a Schimke immune-osseous dysplasia patient with SMARCAL1 mutations.
Wang X; Zhang H; Wang X; Zhou W; Dong L; Li N; He Q
Stem Cell Res; 2023 Oct; 72():103217. PubMed ID: 37788557
[TBL] [Abstract][Full Text] [Related]
29. Clinical and molecular evidence of possible digenic inheritance for MFN2/GDAP1 genes in Charcot-Marie-Tooth disease.
Barreda Fierro R; Herrera Mora P; Zenteno JC; Villarroel Cortés CE
Neuromuscul Disord; 2020 Dec; 30(12):986-990. PubMed ID: 33187793
[TBL] [Abstract][Full Text] [Related]
30. Late onset CMT2A in a Family with an MFN2 Variant: c.2222T>G (p.Leu741Trp).
Lin HP; Ho KWD; Jerath NU
J Neuromuscul Dis; 2019; 6(2):259-261. PubMed ID: 31127728
[TBL] [Abstract][Full Text] [Related]
31. A novel double mutation in cis in MFN2 causes Charcot-Marie-Tooth neuropathy type 2A.
Park SY; Kim SY; Hong YH; Cho SI; Seong MW; Park SS
Neurogenetics; 2012 Aug; 13(3):275-80. PubMed ID: 22526351
[TBL] [Abstract][Full Text] [Related]
32. Mitofusin 2 gene mutation causing early-onset CMT2A with different progressive courses.
Lv H; Wang L; Li W; Qiao X; Li Y; Wang Z; Yuan Y
Clin Neuropathol; 2013; 32(1):16-23. PubMed ID: 22762946
[TBL] [Abstract][Full Text] [Related]
33. MFN2 deletion of exons 7 and 8: founder mutation in the UK population.
Carr AS; Polke JM; Wilson J; Pelayo-Negro AL; Laura M; Nanji T; Holt J; Vaughan J; Rankin J; Sweeney MG; Blake J; Houlden H; Reilly MM
J Peripher Nerv Syst; 2015 Jun; 20(2):67-71. PubMed ID: 26114802
[TBL] [Abstract][Full Text] [Related]
34. Autosomal recessive MFN2-related Charcot-Marie-Tooth disease with diaphragmatic weakness: Case report and literature review.
Tan CA; Rabideau M; Blevins A; Westbrook MJ; Ekstein T; Nykamp K; Deucher A; Harper A; Demmer L
Am J Med Genet A; 2016 Jun; 170(6):1580-4. PubMed ID: 26955893
[TBL] [Abstract][Full Text] [Related]
35. A late-onset and mild form of Charcot-Marie-Tooth disease type 2 caused by a novel splice-site mutation within the Mitofusin-2 gene.
Kotruchow K; Kabzińska D; Hausmanowa-Petrusewicz I; Kochański A
Acta Myol; 2013 Dec; 32(3):166-9. PubMed ID: 24803844
[TBL] [Abstract][Full Text] [Related]
36. A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients.
Choi BO; Nakhro K; Park HJ; Hyun YS; Lee JH; Kanwal S; Jung SC; Chung KW
Clin Genet; 2015 Jun; 87(6):594-8. PubMed ID: 24863639
[TBL] [Abstract][Full Text] [Related]
37. Generation of a human iPSC line (HIMRi001-A) from a patient with filaminopathy.
Daya NM; Mavrommatis L; Zhuge H; Athamneh M; Roos A; Gläser D; Doering K; Zaehres H; Vorgerd M; Güttsches AK
Stem Cell Res; 2023 Oct; 72():103210. PubMed ID: 37748332
[TBL] [Abstract][Full Text] [Related]
38. The Charcot-Marie Tooth Disease Mutation R94Q in MFN2 Decreases ATP Production but Increases Mitochondrial Respiration under Conditions of Mild Oxidative Stress.
Wolf C; Zimmermann R; Thaher O; Bueno D; Wüllner V; Schäfer MKE; Albrecht P; Methner A
Cells; 2019 Oct; 8(10):. PubMed ID: 31640251
[TBL] [Abstract][Full Text] [Related]
39. Mutational mechanisms in MFN2-related neuropathy: compound heterozygosity for recessive and semidominant mutations.
Piscosquito G; Saveri P; Magri S; Ciano C; Di Bella D; Milani M; Taroni F; Pareyson D
J Peripher Nerv Syst; 2015 Dec; 20(4):380-6. PubMed ID: 26306937
[TBL] [Abstract][Full Text] [Related]
40. Gene Repair of iPSC Line with GARS (G294R) Mutation of CMT2D Disease by CRISPR/Cas9.
Lu PJ; Zhang P; Liu YC; Jing N; Guo YN; Wang PS; Su LL; Guo Q; Ma Q; Xu YM; Zhang ST
Curr Med Sci; 2023 Apr; 43(2):261-267. PubMed ID: 36932303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
